scholarly article | Q13442814 |
P50 | author | Loïc Guillevin | Q88410079 |
P2093 | author name string | Eric Hachulla | |
Luc Mouthon | |||
David Launay | |||
Marc Lambert | |||
Pierre-Yves Hatron | |||
Christian Pagnoux | |||
Martine Remy-Jardin | |||
Sandrine Morell-Dubois | |||
Pascal de Groote | |||
Regis Matran | |||
Viviane Queyrel | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pulmonary hypertension | Q1128595 |
P304 | page(s) | 1005-1011 | |
P577 | publication date | 2007-04-15 | |
P1433 | published in | The Journal of Rheumatology | Q7743623 |
P1476 | title | Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease. | |
P478 | volume | 34 |
Q35617799 | Associated pulmonary arterial hypertension in connective tissue diseases |
Q38218044 | Clinical and laboratory profiles of 136 systemic sclerosis patients with and without echocardiographically detected pulmonary hypertension |
Q61807910 | Comprehensive Exercise Capacity and Quality of Life Assessments Predict Mortality in Patients with Pulmonary Arterial Hypertension |
Q38071978 | Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis |
Q34430183 | Human pentraxin 3 (PTX3) as a novel biomarker for the diagnosis of pulmonary arterial hypertension |
Q33649222 | Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertension. |
Q33681073 | Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury |
Q35993982 | Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study |
Q50051189 | Multiparametric Magnetic Resonance Imaging in the Assessment of Pulmonary Hypertension: Initial Experience of a One-Stop Study. |
Q33727800 | Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience |
Q36447388 | Pathogenic mechanisms of pulmonary arterial hypertension |
Q89566570 | Prevalence of pulmonary hypertension in patients with systemic sclerosis and mixed connective tissue disease |
Q37133823 | Provider recognition and response to echocardiographic findings indicating pulmonary hypertension in the Veterans affairs medical center population |
Q59303969 | Pulmonary arterial hypertension |
Q37976985 | Pulmonary hypertension in chronic hypersensitivity pneumonitis |
Q38075430 | Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis |
Q35035897 | Relevance of partitioning DLCO to detect pulmonary hypertension in systemic sclerosis |
Q33919119 | Scleroderma lung disease |
Q38135045 | Screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension: a systematic review. |
Q35857181 | Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension |
Q36691452 | Use of echocardiographic pulmonary acceleration time and estimated vascular resistance for the evaluation of possible pulmonary hypertension |